An 84-year-old male presented with a history of a slowly growing lesion beneath the right lower lid. Examination showed a right-sided mass in the inferior bulbar conjunctiva, measuring approximately 10 × 6 mm. The lesion was excised and showed a giant cell-rich solitary fibrous tumour (GCR-SFT) with pseudo-vascular spaces with benign cytology, with STAT6, expressed in the spindle, ovoid, and tumour giant cells. A second case, a 26-year-old white female, presented with a 12-month history of a gradually expanding lesion in left inferior bulbar conjunctiva. Examination showed a well-defined, dome-shaped pink fleshy mass of 10 × 7 × 2 mm, on the inferior bulbar conjunctiva and abutting the inferior fornix. Excision followed by histology showed a similar appearance to the first case except that the multinucleate giant cells closely resembled Touton giant cells and did not show the rather hyperchromatic crowded nuclei of the giant cells observed in the first case. No pseudo-vascular spaces were identified. The tumour cells, including the Touton-like multinucleate giant cells, displayed nuclear positivity for STAT6. An unexpected feature was the presence of a Melan A- and Sox10-positive population amongst the GCR-SFT, postulated to be a subepithelial melanocytic nevus colliding with the GCR-SFT.

1.
Dei Tos
AP
,
Seregard
S
,
Calonje
E
,
Chan
JK
,
Fletcher
CD
.
Giant cell angiofibroma. A distinctive orbital tumor in adults
.
Am J Surg Pathol
.
1995
Nov
;
19
(
11
):
1286
93
.
[PubMed]
0147-5185
2.
Grossniklaus
HE
,
Green
WR
,
Wolff
SM
,
Iliff
NT
.
Hemangiopericytoma of the conjunctiva. Two cases
.
Ophthalmology
.
1986
Feb
;
93
(
2
):
265
7
.
[PubMed]
0161-6420
3.
Pecorella
I
,
Cruciani
F
,
Russo
V
.
A solitary fibrous tumour of the eyelid
.
Med Princ Pract
.
2014
;
23
(
2
):
170
3
.
[PubMed]
1011-7571
4.
Hayashi
N
,
Borodic
G
,
Karesh
JW
,
Tolentino
MJ
,
Remulla
HD
,
Van Wesep
RA
, et al.
Giant cell angiofibroma of the orbit and eyelid
.
Ophthalmology
.
1999
Jun
;
106
(
6
):
1223
9
.
[PubMed]
0161-6420
5.
Song
A
,
Syed
N
,
Kirby
PA
,
Carter
KD
.
Giant cell angiofibroma of the ocular adnexae
.
Arch Ophthalmol
.
2005
Oct
;
123
(
10
):
1438
43
.
[PubMed]
0003-9950
6.
Cheah
AL
,
Billings
SD
,
Goldblum
JR
,
Carver
P
,
Tanas
MZ
,
Rubin
BP
.
STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics
.
Pathology
.
2014
Aug
;
46
(
5
):
389
95
.
[PubMed]
0031-3025
7.
Doyle
LA
,
Vivero
M
,
Fletcher
CD
,
Mertens
F
,
Hornick
JL
.
Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics
.
Mod Pathol
.
2014
Mar
;
27
(
3
):
390
5
.
[PubMed]
0893-3952
8.
Yoshida
A
,
Tsuta
K
,
Ohno
M
,
Yoshida
M
,
Narita
Y
,
Kawai
A
, et al.
STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors
.
Am J Surg Pathol
.
2014
Apr
;
38
(
4
):
552
9
.
[PubMed]
0147-5185
9.
Mohanty
SK
,
Sharma
S
,
Pradhan
D
,
Kandukuri
SR
,
Farahani
N
,
Barry
C
, et al.
Microphthalmia-associated transcription factor (MiTF): promiscuous staining patterns in fibrohistiocytic lesions is a potential pitfall
.
Pathol Res Pract
.
2018
Jun
;
214
(
6
):
821
5
.
[PubMed]
0344-0338
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.